Product Information
TERBUTALINE SULFATE 5 MG TAB is a generic product labeled by Amneal Pharmaceuticals of New York LLC, priced at $0.6377 per EA under NDC 00115262201. Its NADAC has been published 263 times since Nov 28, 2013.
FDA first approved this application on Jun 26, 2001. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Amneal Pharmaceuticals of New York LLCNDC
00115262201
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
TERBUTALINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA075877FDA Approved
6/26/2001
TE Code
AB
On Market Since
6/26/2001
Price Statistics
The NADAC for TERBUTALINE SULFATE 5 MG TAB has been published 263 times since Nov 28, 2013, and over the history we have for it it has risen 97.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6377 per EA |
|---|---|
| All-time high | $1.8211 (Jun 12, 2024) |
| All-time low | $0.3222 (Nov 28, 2013) |
| 52-week high | $1.3632 |
| 52-week low | $0.6377 |
| Median price | $1.2734 |
| Average price | $1.3074 |
| Largest weekly change | +126.8% (Dec 18, 2013) |
| Weeks tracked | 263 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the TERBUTALINE SULFATE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Amneal Pharmaceuticals of New York LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
TERBUTALINE SULFATE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TERBUTALINE SULFATE 5 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for TERBUTALINE SULFATE 5 MG TAB, manufactured by Amneal Pharmaceuticals of New York LLC, is $0.6377 per EA (NDC 00115262201), effective Sep 30, 2026.
How has the price of TERBUTALINE SULFATE 5 MG TAB changed over time?
Over the history we have for it, the NADAC for TERBUTALINE SULFATE 5 MG TAB has risen 97.9%. It has been tracked across 263 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for TERBUTALINE SULFATE 5 MG TAB?
Since Nov 28, 2013, the NADAC for TERBUTALINE SULFATE 5 MG TAB has ranged from a low of $0.3222 (Nov 28, 2013) to a high of $1.8211 (Jun 12, 2024), with a median of $1.2734 per EA.
Are there cheaper alternatives to TERBUTALINE SULFATE 5 MG TAB?
No other NADAC-published product currently shares the active ingredient and strength of TERBUTALINE SULFATE 5 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures TERBUTALINE SULFATE 5 MG TAB?
TERBUTALINE SULFATE 5 MG TAB (NDC 00115262201) is labeled by Amneal Pharmaceuticals of New York LLC, and CMS classifies it as a generic product.